⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Figure S5 from ESRRB inhibits the TGF-β signaling pathway to drive cell proliferation in cervical cancer

Qin-Shu Li Peng‐Sheng Zheng

View Full Paper

Ask AI

Bookmark

Share

Abstract

Fig. S5 describes supplementary data related to ESRRB transactivated SMAD7 and MYC transactivated ESRRB; survival curves of CDKN1A,CCNA2, MYC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523d55 https://doi.org/10.1158/0008-5472.27028393.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S4 from ESRRB inhibits the TGF-β signaling pathway to drive cell proliferation in cervical cancer2024
2Figure S1 from ESRRB inhibits the TGF-β signaling pathway to drive cell proliferation in cervical cancer2024
3Figure S2 from ESRRB inhibits the TGF-β signaling pathway to drive cell proliferation in cervical cancer2024
4Data from ESRRB inhibits the TGF-β signaling pathway to drive cell proliferation in cervical cancer2024
5Figure S3 from ESRRB inhibits the TGF-β signaling pathway to drive cell proliferation in cervical cancer2024